Comparison of Glycemic Excursion in Patients with New Onset Type 2 Diabetes Mellitus before and after Treatment with Repaglinide

Due to industrialization and sedentary life, incidence of type 2 diabetes (DM2) is increasing seriously. Repaglinide is a glucose reducing agent that predominantly reduces post-prandial glucose. Continuous glucose monitoring system (CGMS) monitors blood glucose excursions over a 3-day period. CGMS c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hezarkhani, Sharabeh, Bonakdaran, Shokufeh, Rajabian, Reza, Shahini, Najmeh, Marjani, Abdoljalal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601336/
https://www.ncbi.nlm.nih.gov/pubmed/23526382
http://dx.doi.org/10.2174/1874091X01307010019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601336/
https://www.ncbi.nlm.nih.gov/pubmed/23526382
http://dx.doi.org/10.2174/1874091X01307010019

Ejemplares similares